Expertise in
1
conditions

Ilhan Hacibekiroglu

Prof Dr. Cemil Tascioglu City Hospital
Istanbul, TR 
Expertise in
1
conditions
Prof Dr. Cemil Tascioglu City Hospital
Istanbul, TR 

Overview

Ilhan Hacibekiroglu practices practicing medicine in Istanbul, Turkey.

Ms. Hacibekiroglu is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, Small Cell Lung Cancer (SCLC), Lung Cancer, and Tissue Biopsy.

She is actively involved in clinical research, co-authoring 94 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Prof Dr. Cemil Tascioglu City Hospital
Istanbul, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drugs: TAK-788, Pemetrexed, Cisplatin, Carboplatin
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Drug, Biological
Study Drugs: Dostarlimab, Carboplatin, Paclitaxel, Niraparib
Study Phase: Phase 3
View 1 Less Clinical Trial

94 Total Publications

Association between serum preptin levels and bone metastasis in newly diagnosed prostate cancer: a prospective exploratory study.
Association between serum preptin levels and bone metastasis in newly diagnosed prostate cancer: a prospective exploratory study.
Journal: Journal of bone oncology
Published: June 12, 2026

Frequently Asked Questions about Ilhan Hacibekiroglu

Is Ilhan Hacibekiroglu a top-rated expert for Triple-Negative Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ilhan Hacibekiroglu is classified as an Advanced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ilhan Hacibekiroglu participate in research or clinical trials?

Yes. Ilhan Hacibekiroglu has published 94 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Ilhan Hacibekiroglu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hacibekiroglu's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile